JP Stock MarketDetailed Quotes

4551 Torii Pharmaceutical

Watchlist
  • 5230
  • +380+7.84%
20min DelayMarket Closed May 2 15:30 JST
150.62BMarket Cap29.16P/E (Static)

About Torii Pharmaceutical Company

Torii Pharmaceutical Co Ltd is a major drug manufacturing company. The company utilizes strategic partnerships with other pharmaceutical companies in order to combine research and marketing functions. Torii's key therapeutic areas include renal diseases, hemodialysis, HIV, skin diseases, and allergens. The vast majority of the company's net mainstay product sales are derived from the renal diseases and hemodialysis operations, followed by HIV. Torii's places its strategic focus on prompt market penetration and expansion of new products as well as maximizing values of mainstay products in each priority area.

Company Profile

Symbol4551
Company NameTorii Pharmaceutical
Founded1921-11-01
MarketTSE Prime
Fiscal Year Ends12-31
AddressTorii Nihonbashi Buildingg, 4-1, Nihonbashi-Honcho 3-chome, Chuo-ku
Zip Code103-8439
Phone03-3231-6811

Company Executives

  • Name
  • Position
  • Salary
  • Goichi Matsuda
  • Director, President and Chief Executive Officer
  • --
  • Nobumasa Kondo
  • Director and Vice President
  • --
  • Mihoko Manabe
  • Independent Director
  • --
  • Takaharu Matsumura
  • Independent Director
  • --
  • Kenichi Fujita
  • Independent Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More